RiverVest Venture Fund IV, L.P.'s Net Worth

$0

Estimate Recalculated Nov 1, 2024 03:59AM EST

Who is RiverVest Venture Fund IV, L.P.?

RiverVest Venture Fund IV, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Reneo Pharmaceuticals, Inc., Xilio Therapeutics, Inc., and SPRUCE BIOSCIENCES, INC..

SEC CIK

RiverVest Venture Fund IV, L.P.'s CIK is 0001725443

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.43

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+762.46%
2.13M
$15.00
—
2.41M
Apr 9
Form 3
—
0
—
—
0
No matching records found

SPRUCE BIOSCIENCES, INC. (SPRB) Snapshot price: $0.4418

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+113.17%
2.15M
$15.00
$3,750,000.00
4.05M
Oct 14
Form 3
—
0
—
—
0
No matching records found

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.44M
$16.00
—
1.44M
Oct 26
Form 3
—
0
—
—
0
No matching records found